ADVFN ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Caratteristiche principali

Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
West Pharmaceutical Services Inc

West Pharmaceutical Services Inc (WST)

316,31
4,14
(1,33%)
Chiuso 04 Giugno 10:00PM
316,31
0,00
( 0,00% )
Pre Mercato: 3:28PM

West Pharmaceutical Services Inc (WST) Operazioni degli insider

-
Filtra per:
Data Nome del titolare Azioni transazionate Intervallo di valore ($) Tipo di transazione Intervallo di prezzo ($) Azioni a fine dichiarazione % di variazione
2026-05-12Mr. Shane A. CampbellSVP & Chief Proprietary Segment Officer-219,2668,42kDerivative Exercise and Sale312,07613,00-
2026-05-12Mr. Shane A. CampbellSVP & Chief Proprietary Segment Officer550,330,00Derivative Exercise and Retained Stock-613,00878,17%
2026-04-27Ms. Annette F. FavoriteChief HR Officer & Senior VP-2,82k624,62kDerivative Exercise and Sale83,47 - 305,2016,83k-
2026-04-27Mr. Chad R. WintersVP of Finance & CAO-896,00114,19kDerivative Exercise and Sale173,22 - 300,671,52k-
2026-02-20Mr. Rudy J. PoussotSVP of Strategy & Corporate Development253,840,00Derivative Exercise and Retained Stock-561,0082,64%
2026-02-20Mr. Rudy J. PoussotSVP of Strategy & Corporate Development-129,5531,24kDerivative Exercise and Sale241,12561,00-
2026-02-20Mr. Charles WitherspoonVP & Treasurer38,150,00Derivative Exercise and Retained Stock-1,41k2,79%
2026-02-20Mr. Charles WitherspoonVP & Treasurer-22,075,32kDerivative Exercise and Sale241,121,41k-
2026-02-20Mr. Chad R. WintersVP of Finance & CAO59,140,00Derivative Exercise and Retained Stock-1,52k4,04%
2026-02-20Mr. Chad R. WintersVP of Finance & CAO-30,187,28kDerivative Exercise and Sale241,121,52k-
2026-02-18Mr. Rudy J. PoussotSVP of Strategy & Corporate Development54,490,00Derivative Exercise and Retained Stock-307,0021,58%
2026-02-18Mr. Rudy J. PoussotSVP of Strategy & Corporate Development-27,816,90kDerivative Exercise and Sale248,26307,00-
2026-02-17Mr. Charles WitherspoonVP & Treasurer-41,5210,10kSale to Issuer243,191,37k-2,94%
2026-02-17Mr. Chad R. WintersVP of Finance & CAO-50,5812,30kSale to Issuer243,191,46k-3,34%
2026-02-17Mr. Eric M. GreenNon-Independent Chair of the Board, President & CEO-1,31k317,46kSale to Issuer243,19175,16k-0,74%
2026-02-18Mr. Eric M. GreenNon-Independent Chair of the Board, President & CEO745,260,00Derivative Exercise and Retained Stock-175,16k0,43%
2026-02-18Mr. Eric M. GreenNon-Independent Chair of the Board, President & CEO-573,55142,39kDerivative Exercise and Sale248,26175,16k-
2026-02-17Ms. Annette F. FavoriteChief HR Officer & Senior VP-150,4436,59kSale to Issuer243,1917,37k-0,86%
2026-02-18Ms. Annette F. FavoriteChief HR Officer & Senior VP99,730,00Derivative Exercise and Retained Stock-17,37k0,58%
2026-02-18Ms. Annette F. FavoriteChief HR Officer & Senior VP-35,768,88kDerivative Exercise and Sale248,2617,37k-
2026-02-11Mr. Robert W. McMahonSenior VP & CFO2,98k0,00Derivative Exercise and Retained Stock-2,98k-
2026-02-11Mr. Robert W. McMahonSenior VP & CFO-1,25k307,71kDerivative Exercise and Sale246,162,98k-